Eberle R, Courtney R J
Infect Immun. 1981 Mar;31(3):1062-70. doi: 10.1128/iai.31.3.1062-1070.1981.
A reliable and reproducible method for determining specific reactivity to herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) in human sera has been developed. Human sera were used to immunoprecipitate HSV-specific glycoprotein antigens from both HSV-1- and HSV-2-infected cell extracts. The viral glycoproteins precipitated from these extracts were then analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis to detect specific reactivity of the sera with distinct type-specific antigens of HSV-1, HSV-2, or both as well as with type-common glycoprotein antigens. By examining a large number of human sera, this method was found to be more reliable than the standard microneutralization test in discriminating between single-positive (positive for HSV-1 or HSV-2) and double-positive (positive for HSV-1 and HSV-2) sera.
已开发出一种可靠且可重复的方法,用于测定人血清对1型和2型单纯疱疹病毒(HSV-1和HSV-2)的特异性反应性。用人血清从HSV-1和HSV-2感染的细胞提取物中免疫沉淀HSV特异性糖蛋白抗原。然后通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳分析从这些提取物中沉淀的病毒糖蛋白,以检测血清与HSV-1、HSV-2或两者的不同型特异性抗原以及型共同糖蛋白抗原的特异性反应性。通过检测大量人血清,发现该方法在区分单阳性(HSV-1或HSV-2阳性)和双阳性(HSV-1和HSV-2阳性)血清方面比标准微量中和试验更可靠。